Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by archeo753on Jan 02, 2024 9:46am
105 Views
Post# 35806871

Market Cap

Market CapSo if the goal is to depress the market cap of CZO to such a low level that the merger looks like the only path forward they are succeeding.  Pathetic.  AEZS is starting to look like the dominant company especially when you take into account the near 50% premium that AEZS shareholders get with the warrants they recieve prior to closing.

"Additionally, as part of the transaction, Aeterna will issue to its shareholders immediately prior to the closing of the transaction 0.47698 of a share purchase warrant for each Aeterna common share held as of such date. Each transaction warrant will have a term of three years and each whole transaction warrant will be exercisable to purchase one common share of Aeterna at a nominal exercise price of one U.S. cent. Holders of Aeterna's currently outstanding warrants will also be issued transaction warrants in accordance with the anti-dilution provisions of such warrants. "

<< Previous
Bullboard Posts
Next >>